Philippe L. L’Allier

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Böhm, Kazuomi Kario, David E. Kandzari et al. · The Lancet · 2020 · 587 citations

Medicine, Cardiology, Nephrology +8

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters et al. · European Heart Journal · 2020 · 313 citations · Full text

Medicine, Cardiology, Pharmacology +13

Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions

Jean‐Claude Tardif, Jean Grégoire, Philippe L. L’Allier et al. · Circulation · 2004 · 288 citations

Medicine, Pharmacology, Pharmacotherapy +17

In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques

Sergio Waxman, Simon Dixon, Philippe L. L’Allier et al. · JACC. Cardiovascular imaging · 2009 · 272 citations

Medicine, Biomedical Engineering, Cardiology +16